NCOA6 anticorps (AA 1954-2064)
Aperçu rapide pour NCOA6 anticorps (AA 1954-2064) (ABIN2318349)
Antigène
Voir toutes NCOA6 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 1954-2064
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- NCOA6 (Nuclear Receptor Coactivator 6, Activating Signal Cointegrator 2, ASC-2, Amplified in Breast Cancer Protein 3, Cancer-amplified Transcriptional Coactivator ASC-2, Nuclear Receptor Coactivator RAP250, NRC RAP250, Nuclear Receptor-activating Protein, 250kD, Peroxisome Proliferator-activated Receptor-interacting Protein, PPAR-interacting Protein, PRIP, Thyroid Hormone Receptor-binding Protein, AIB3, KIAA0181, RAP250, TRBP)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- Partial recombinant corresponding to aa1954-2064 from NCOA6 (NP_054790) with GST tag. MW of the GST tag alone is 26kD.
-
Isotype
- IgG2a kappa
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- NCOA6 (Nuclear Receptor Coactivator 6 (NCOA6))
-
Autre désignation
- NCOA6
-
NCBI Accession
- NM_014071, NP_054790
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Lipid Metabolism by PPARalpha
Antigène
-